✦ LIBER ✦

PCV3 UTILIZATION OF RECOMMENDED DRUG THERAPY IN ACUTE CORONARY SYNDROME

✍ Scribed by CK Patel; PL McCollam; JP Bae

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV43 PREDICTORS OF CLOPIDOGREL THERAPY

✍ PL McCollam; SS Shetty 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCV38 THIENOPYRIDINE THERAPY IN ACUTE CO

✍ MJ Lage; PL McCollam; JP Bae 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PCV51 Cost of Acute Coronary Syndrome in

✍ S. Wieser; I. Rüthemann; S. De boni; K. Eichler; M. Pletscher; D. Radovanovic; H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCV24 BUDGET IMPACT OF GUIDELINE ADHEREN

✍ AS Neubauer; U Zeymer; H Blankenfeld; D Marschall; B Ehlken; C Plesnila-Frank; K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCV92 DERIVING UTILITY VALUES FOR ACUTE

✍ A Cordony; N Price; F Gonzalo; C Yuen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCV62 THE BURDEN OF ACUTE CORONARY SYNDR

✍ D Liew; N Price 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB